Survival analysis tracks the event-time distribution across follow-up rather than reducing every participant to a single fixed-time result. This allows clinical investigators to retain information from participants observed for different lengths of time and to describe how the chance of remaining event-free changes as follow-up progresses. It is therefore suited to recurrence, hospitalization, and death outcomes.
Right-censored observations contribute the follow-up that was actually observed without being treated as if the event occurred. A participant may reach the observation endpoint without an event or leave early, so the analysis records incomplete event-time information. Incorporating these observations helps avoid discarding participants simply because their full event experience is not known.
Kaplan-Meier curves and Cox proportional-hazards models answer related but different questions. Kaplan-Meier analysis summarizes the survival pattern over time, whereas a Cox model compares hazards between groups. Using both can show the observed time-course and the relative group difference, providing complementary evidence when evaluating a clinical treatment, prognosis, or risk factor.
A clinical time-to-event analysis begins by specifying the event and measuring elapsed follow-up for each participant. Investigators then record whether the event occurred, observation ended without an event, or the participant left early, and apply a survival-analysis method. This workflow makes the endpoint explicit and ensures that unequal follow-up is represented in the results.
These outcomes are especially useful when a study must distinguish whether an event occurred from when it occurred. Two groups could have similar event experiences at one point yet differ in the timing of recurrence or hospitalization. Time-to-event analysis therefore supports treatment evaluation and prognosis by retaining the temporal pattern of clinical outcomes.
For clinical risk-factor research, the outcome can be used to examine how a factor relates to the timing of an event, not merely whether the event appears during the study. Hazard comparisons can help characterize differences between groups, while survival estimates show how those differences unfold over follow-up. This is also relevant to prognostic assessment.